Ronald G. Gelbman, Director at HAEMONETICS CORP (HAE), sold 33,852 shares at $118.26 ($4.0M) on 2019-11-11, disclosed to the SEC on 2019-11-13.
Open-market sale of $4.0M HAE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $118.26 | 16,926 | $2.0M | 50.0% |
| 2 | $118.26 | 16,926 | $2.0M | 50.0% |
| Total | $118.26 avg | 33,852 | $4.0M | 100% |
| Filing → |
| HAE | SELL | 2018-12-18 | $892K | — | Filing → |
| HAE | SELL | 2017-11-17 | $331K | — | Filing → |
| HAE | SELL | 2017-04-27 | $343K | — | Filing → |